Statistical parametric mapping: the analysis of functional brain images WD Penny, KJ Friston, JT Ashburner, SJ Kiebel, TE Nichols Elsevier, 2011 | 5010 | 2011 |
Alzheimer's disease: connecting findings from graph theoretical studies of brain networks BM Tijms, AM Wink, W De Haan, WM van der Flier, CJ Stam, P Scheltens, ... Neurobiology of aging 34 (8), 2023-2036, 2013 | 447 | 2013 |
Resting-state fMRI changes in Alzheimer's disease and mild cognitive impairment MAA Binnewijzend, MM Schoonheim, E Sanz-Arigita, AM Wink, ... Neurobiology of aging 33 (9), 2018-2028, 2012 | 446 | 2012 |
Denoising functional MR images: a comparison of wavelet denoising and Gaussian smoothing AM Wink, JBTM Roerdink IEEE transactions on medical imaging 23 (3), 374-387, 2004 | 360 | 2004 |
Cerebral blood flow measured with 3D pseudocontinuous arterial spin-labeling MR imaging in Alzheimer disease and mild cognitive impairment: a marker for disease severity MAA Binnewijzend, JPA Kuijer, MR Benedictus, WM van der Flier, ... Radiology 267 (1), 221-230, 2013 | 314 | 2013 |
Cortical atrophy patterns in multiple sclerosis are non-random and clinically relevant MD Steenwijk, JJG Geurts, M Daams, BM Tijms, AM Wink, LJ Balk, ... Brain 139 (1), 115-126, 2016 | 313 | 2016 |
Thalamus structure and function determine severity of cognitive impairment in multiple sclerosis MM Schoonheim, HE Hulst, RB Brandt, M Strik, AM Wink, BMJ Uitdehaag, ... Neurology 84 (8), 776-783, 2015 | 242 | 2015 |
A review of wavelet denoising in MRI and ultrasound brain imaging A Pizurica, AM Wink, E Vansteenkiste, W Philips, BJ Roerdink Current Medical Imaging 2 (2), 247-260, 2006 | 191 | 2006 |
Resting‐state networks in awake five‐to eight‐year old children HMA de Bie, M Boersma, S Adriaanse, DJ Veltman, AM Wink, ... Human brain mapping 33 (5), 1189-1201, 2012 | 180 | 2012 |
Longitudinal changes in total brain volume in schizophrenia: relation to symptom severity, cognition and antipsychotic medication J Veijola, JY Guo, JS Moilanen, E Jääskeläinen, J Miettunen, M Kyllönen, ... PloS one 9 (7), e101689, 2014 | 152 | 2014 |
Monofractal and multifractal dynamics of low frequency endogenous brain oscillations in functional MRI AM Wink, E Bullmore, A Barnes, F Bernard, J Suckling Human brain mapping 29 (7), 791-801, 2008 | 138 | 2008 |
Single-subject grey matter graphs in Alzheimer's disease BM Tijms, C Möller, H Vrenken, AM Wink, W de Haan, WM van der Flier, ... PloS one 8 (3), e58921, 2013 | 136 | 2013 |
Brain network alterations in Alzheimer's disease measured by eigenvector centrality in fMRI are related to cognition and CSF biomarkers MAA Binnewijzend, SM Adriaanse, WM Van der Flier, CE Teunissen, ... Human brain mapping 35 (5), 2383-2393, 2014 | 126 | 2014 |
Fast eigenvector centrality mapping of voxel-wise connectivity in functional magnetic resonance imaging: implementation, validation, and interpretation AM Wink, JC de Munck, YD van der Werf, OA van den Heuvel, F Barkhof Brain connectivity 2 (5), 265-274, 2012 | 123 | 2012 |
Endogenous multifractal brain dynamics are modulated by age, cholinergic blockade and cognitive performance J Suckling, AM Wink, FA Bernard, A Barnes, E Bullmore Journal of neuroscience methods 174 (2), 292-300, 2008 | 119 | 2008 |
Age and cholinergic effects on hemodynamics and functional coherence of human hippocampus AM Wink, F Bernard, R Salvador, E Bullmore, J Suckling Neurobiology of aging 27 (10), 1395-1404, 2006 | 119 | 2006 |
Increased default-mode network centrality in cognitively impaired multiple sclerosis patients AJC Eijlers, KA Meijer, TM Wassenaar, MD Steenwijk, BMJ Uitdehaag, ... Neurology 88 (10), 952-960, 2017 | 115 | 2017 |
ExploreASL: an image processing pipeline for multi-center ASL perfusion MRI studies HJMM Mutsaerts, J Petr, P Groot, P Vandemaele, S Ingala, AD Robertson, ... Neuroimage 219, 117031, 2020 | 109 | 2020 |
Alzheimer disease and behavioral variant frontotemporal dementia: automatic classification based on cortical atrophy for single-subject diagnosis C Möller, YAL Pijnenburg, WM van der Flier, A Versteeg, B Tijms, ... Radiology 279 (3), 838-848, 2016 | 98 | 2016 |
Safety, tolerability and efficacy of the glutaminyl cyclase inhibitor PQ912 in Alzheimer’s disease: results of a randomized, double-blind, placebo-controlled phase 2a study P Scheltens, M Hallikainen, T Grimmer, T Duning, AA Gouw, ... Alzheimer's research & therapy 10, 1-14, 2018 | 92 | 2018 |